Jason P Rhodes's Net Worth
$5.79 Million
Who is Jason P Rhodes?
Jason P Rhodes has an estimated net worth of $5.79 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Generation Bio Co., Replimune Group, Inc., Gemini Therapeutics, Inc. /DE, and Epizyme, Inc..
SEC CIK
Jason P Rhodes's CIK is 0001577014
Past Insider Trading and Trends
2014 was Jason P Rhodes's most active year for acquiring shares with 17 total transactions. Jason P Rhodes's most active month to acquire stocks was the month of May. 2014 was Jason P Rhodes's most active year for disposing of shares, totalling 28 transactions. Jason P Rhodes's most active month to dispose stocks was the month of June. 2014 saw Jason P Rhodes paying a total of $566,550.00 for 400,406 shares, this is the most they've acquired in one year. In 2014 Jason P Rhodes cashed out on 608,000 shares for a total of $6,355,922.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -1.98% | -46.53K |
$30.05 | -$1,398,346.70 | 2.31M |
Scheduled
|
Mar 1
| ||
Form 4
| -3.14% | -807.84K |
$24.32 | -$19,626,902.97 | 24.9M |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
| -5.35% | -500.79K |
$22.68 | -$11,339,780.44 | 8.86M |
Scheduled
|
Feb 21 - Feb 23
| ||
Form 4
| -6.96% | -510.15K |
$23.26 | -$11,867,292.26 | 6.82M |
Scheduled
|
Feb 15 - Feb 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 934.58K |
$10.70 | $10,000,016.70 | 934.58K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +361.95% | 7.64M |
—
|
—
| 9.75M |
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Generation Bio Co. (GBIO) Snapshot price: $2.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -62.76% | -81.09K |
$25.18 | -$2,059,519.16 | 48.11K |
Scheduled
|
Sep 27 - Sep 29
| ||
Form 4
| -62.30% | -135.00K |
$26.02 | -$3,511,992.53 | 81.7K |
Scheduled
|
Sep 22 - Sep 24
| ||
Form 4
| -98.08% | -31.01K |
$25.86 | -$801,618.16 | 608 |
Scheduled
|
Jun 24
| ||
Form 4
| -39.91% | -185.08K |
$25.05 | -$4,635,967.02 | 278.64K |
Scheduled
|
Jun 21 - Jun 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -100.00% | -140.68K |
$25.92 | -$3,646,968.15 |
0
|
Scheduled
|
Apr 12 - Apr 14
| ||
Form 4
| -47.46% | -127.09K |
$28.20 | -$3,583,860.22 | 140.68K |
Scheduled
|
Apr 7 - Apr 9
| ||
Form 4
| +387.54% | 10.04M |
—
|
—
| 12.63M |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -0.58% | -5.56K |
$46.14 | -$256,446.12 | 946K |
Scheduled
|
Jan 26
| ||
Form 4
| -0.13% | -4.32K |
$41.95 | -$181,182.05 | 3.23M |
Scheduled
|
Dec 18
| ||
Form 4
| -0.66% | -65.03K |
$42.18 | -$2,749,720.63 | 9.75M |
Scheduled
|
Dec 15 - Dec 17
| ||
Form 4
| -1.02% | -103.69K |
$43.34 | -$4,494,442.21 | 10.02M |
Scheduled
|
Dec 10 - Dec 14
| ||
Form 4
| -2.04% | -217.36K |
$45.48 | -$9,981,231.21 | 10.41M |
Scheduled
|
Dec 7 - Dec 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 1.1M |
$13.61 | $14,971,000.00 | 1.1M |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 4.45M |
—
|
—
| 4.45M |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $50.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
President, CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +46.81% | 44K |
$0.51 | $22,440.00 | 138K |
Sep 22
| |||
Form 4
| +14.63% | 12K |
$17.25 | -$961,322.79 | 94K |
Scheduled
|
Sep 2
| ||
Form 4
| +17.14% | 12K |
$15.45 | -$843,604.36 | 82K |
Scheduled
|
Aug 4
| ||
Form 4
| +20.69% | 12K |
$16.85 | -$942,201.21 | 70K |
Scheduled
|
Jul 7
| ||
Form 4
| +26.09% | 12K |
$11.90 | -$599,000.41 | 58K |
Scheduled
|
Jun 2
| ||
Form 4
| +35.29% | 12K |
$12.36 | -$512,310.00 | 46K |
Scheduled
|
May 5
| ||
Form 4
| +41.67% | 10K |
$10.28 | -$483,340.00 | 34K |
Scheduled
|
Apr 7
| ||
Form 4
| +500.00% | 20K |
$15.96 | -$1,275,300.00 | 24K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
∞
| 4K |
$10.35 | -$194,734.00 | 4K |
Scheduled
|
Jan 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||